Madrigal Pharmaceuticals (MDGL) Capital Expenditures Growth (5y) (2015 - 2026)
Madrigal Pharmaceuticals (MDGL) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Madrigal Pharmaceuticals |
14.67 Bn |
14.44 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
144.56% |
| Dec 31, 2025 |
-94.87% |
| Sep 30, 2025 |
199.92% |
| Dec 31, 2024 |
11.22% |
| Sep 30, 2024 |
-200.25% |
| Jun 30, 2024 |
165.93% |
| Mar 31, 2024 |
54.16% |
| Dec 31, 2023 |
164.52% |
| Sep 30, 2023 |
91.98% |
| Mar 31, 2023 |
103.62% |
| Dec 31, 2022 |
-25.34% |
| Jun 30, 2022 |
-3.49% |
| Mar 31, 2022 |
91.86% |
| Dec 31, 2021 |
124.08% |
| Dec 31, 2020 |
-11.09% |
| Sep 30, 2020 |
-25.42% |
| Dec 31, 2019 |
70.86% |
| Sep 30, 2019 |
-15.48% |
| Jun 30, 2019 |
-15.33% |
| Mar 31, 2019 |
12.26% |
